BBGBloomberg·2hBusiness
score+0.60
GSK Agrees to Buy Nuvalent for $10.6 Billion
Original
GSK Agrees to Buy Nuvalent for $10.6 Billion
“Acquisition framed as strategic growth opportunity with optimistic language ('seeks to rebuild') and substantial investment value.”